Usefulness of compounds with monacolin K in a case of statins intolerance.

@article{ParraVirto2018UsefulnessOC,
  title={Usefulness of compounds with monacolin K in a case of statins intolerance.},
  author={Alejandro Parra-Virto and Ana Torres do Rego and Pablo Demelo-Rodr{\'i}guez and Jes{\'u}s Mill{\'a}n N{\'u}{\~n}ez-Cort{\'e}s and Lu{\'i}s Antonio {\'A}lvarez-Sala},
  journal={Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis},
  year={2018},
  volume={30 6},
  pages={
          268-270
        }
}
Many patients with familial hypercholesterolaemia (FH) or in secondary prevention situations and with statin intolerance do not achieve LDL-C targets, and require treatment with PCSK9 inhibitors (iPCSK9) and ezetimibe. The case is presented on a patient with FH and total intolerance to statins. Treatment with iPCSK9 and ezetimibe failed to achieve her LDL-C target. A compound with red yeast rice derivatives containing 3mg of monacolin K was added, with good therapeutic compliance, and a very… CONTINUE READING
1
Twitter Mention

Topics from this paper.